Phase II study of Mitonafide in advanced and relapsed colorectal cancer

Investigational New Drugs

Volumn 14, Issue 2, 1996, Pages 223-225

  Abad, Albert ^a   Grávalos, Cristina ^b   Font, Albert ^a   Molina, Francisco ^a   Díaz Puente, María Teresa ^b   Fabregat, Xavier ^c   Benavides, Ana ^d   Martin, Miguel ^d  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d Laboratorios Knoll SA   (Spain)

Author keywords

Colorectal cancer; Mitonafide; Phase II study

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOSTATIC AGENT; MITONAFIDE;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW TOXICITY; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; COLORECTAL CANCER; FEMALE; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MALE; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA;

EID: 0029840944     PISSN: 01676997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00210795     Document Type: Article

References (5)

1. Braña MF, Martínez Sanz A, Castellano JM et al.: Synthesis and cytostatic activity of benz(de)isoquinolin-1,3-diones. Structure-activity relationships. Eur J Med Chem 16(3):207-212, 1981
2. Llombart M, Poveda A, Forner E, Fernández Martos C, Gaspar C, Muñoz M, Olmos T, Ruiz A, Soriano V, Benavides A, Martín M, Schlick E, Guillem V: Phase I study of mitonafide in solid tumors. Invest New Drugs 10:177-181, 1992
3. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State". A practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 12:189-198, 1975
4. Miller AB, Hoogstraten B, Staquet M: Reporting results of cancer treatment. Cancer 47:207-214, 1981
5. Casado A, Díaz-Rubio E, García-Gómez R et al: Phase II study of Mitonafide in 120 hour continuous infusion in non-small cell lung cancer. Proc Am Soc Clin Oncol 12:A347, 1993